Last week, the biotech company Achaogen announced that it was filing for bankruptcy. That might not seem like much news: Businesses crash and burn all the time. But Achaogen, founded in 2002, was an antibiotics company. Its first drug, Zemdri (plazomicin), was approved by the Food and Drug Administration last June.

Read more…

Maksym Kozlenko [CC BY-SA 4.0 (https://creativecommons.org/licenses/by-sa/4.0)], from Wikimedia Commons